Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.aorn.2010.10.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A multicenter prospective observational study appraising the effectiveness of the Supera stent after subintimal recanalization of femoro-popliteal artery occlusion: The SUPERSUB II study.
Catheter Cardiovasc Interv
May 2024
Interventional Radiology Unit, Endovascular Interventions & Research, Foot & Ankle Clinic, Policlinico, Abano Terme, Italy.
Article Synopsis
- The Supera stent is a special medical device that helps improve treatments for difficult artery problems in the leg.
- Researchers studied how effective this stent is after a procedure called subintimal angioplasty, which is used to open blocked arteries.
- The results showed that using the Supera stent led to successful outcomes for almost all patients, and it helped them stay healthy over time with fewer medical resources needed.
Alternative Approaches for Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: The Call for a Personalized Treatment.
Am J Cardiol
April 2024
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Electronic address:
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice.
Int J Mol Sci
April 2023
Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", I-80131 Naples, Italy.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were initially developed for the treatment of diabetes due to their antihyperglycemic activity. However, in the light of the most recent clinical studies, they are revolutionizing the approach to cardiovascular disease in patients with and without diabetes. We aimed to generate real-world data about the use of SGLT2i in patients with T2DM and coronary artery disease (CAD), focusing on their effectiveness in glycemic control, adherence, long-term efficacy, and safety outcomes.
View Article and Find Full Text PDFA retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience.
Seizure
May 2023
IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Bologna, Italy.
Objective: Nearly half of people with epilepsy (PWE) are expected to develop seizure clusters (SC), with the subsequent risk of hospitalization. The aim of the present study was to evaluate the use, effectiveness and safety of intravenous (IV) brivaracetam (BRV) in the treatment of SC.
Methods: Retrospective multicentric study of patients with SC (≥ 2 seizures/24 h) who received IV BRV.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!